C Lorentz
Overview
Explore the profile of C Lorentz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li M, Mindt S, Luck A, Hutzschenreuter U, Kollendt M, Lathan B, et al.
ESMO Open
. 2023 Mar;
8(2):101201.
PMID: 36965262
Introduction: Body surface area (BSA)-based dosing of 5-fluorouracil (5-FU) results in marked inter-individual variability in drug levels, whereas determination of plasma 5-FU concentration and area under the curve (AUC) is...
2.
Nickel S, Suss W, Lorentz C, Trojan A
Public Health
. 2018 Jun;
162:9-15.
PMID: 29929182
Objectives: Between 2001 and 2012, the health authority of Hamburg-Eimsbüttel carried out a health promotion programme for children and their parents in a disadvantaged neighbourhood called Lenzsiedlung. The programme consisted...
3.
Le-Bail P, Lorentz C, Pencreach G, Soultani-Vigneron S, Pontoire B, Giraldo L, et al.
Carbohydr Polym
. 2014 Dec;
117:910-916.
PMID: 25498716
5-Caffeoylquinic acid (chlorogenic acid), is classified in acid-phenols family and as polyphenolic compounds it possesses antioxidant activity. The oxydative modification of chlorogenic acid in foods may lead to alteration of...
4.
Lorentz C, Pencreach G, Soultani-Vigneron S, Rondeau-Mouro C, De Carvalho M, Pontoire B, et al.
Carbohydr Polym
. 2014 Apr;
90(1):152-8.
PMID: 24751024
Chlorogenic acid (5-caffeoylquinic acid) is a hydrophilic phenolic compound with antioxidant properties. Because of its high polarity, these properties may be altered when formulated in oil-based food. There is therefore...
5.
Boulanger N, Baumann C, Beurton R, Elueque H, Gallet P, Grosjean R, et al.
Rhinology
. 2013 Feb;
51(1):77-87.
PMID: 23441315
Objective: This study was aimed to assess the early morphological results of a new septorhinoplasty technique based on disarticulation (SRD) between bony and cartilaginous nose structures. Methodology: A retrospective, multi-judge,...
6.
Lorentz C, Rivier A, Debourgogne A, Sokolowska-Gillois J, Vignaud J, Jankowski R, et al.
Mycoses
. 2011 Jul;
55(2):e8-12.
PMID: 21736631
No abstract available.
7.
Grosjean R, Lorentz C, Jankowski R
Eur Ann Otorhinolaryngol Head Neck Dis
. 2011 Jun;
128(4):203-4.
PMID: 21700524
No abstract available.
8.
Lorentz C, Dulac A, Pencreach G, Ergan F, Richomme P, Soultani-Vigneron S
Biotechnol Lett
. 2010 Sep;
32(12):1955-60.
PMID: 20809284
Chlorogenic acid (5-caffeoyl quinic acid (CQA)) extracted from Hydrangea macrophylla (44%, w/w) with 98% purity, was acylated with palmitic acid by Novozym 435 to yield mono-acylated CQA. Acylation of CQA...
9.
Zheng C, Li L, Haak M, Brors B, Frank O, Giehl M, et al.
Leukemia
. 2006 Apr;
20(6):1028-34.
PMID: 16617318
Despite recent success in the treatment of early-stage disease, blastic phase (BP) of chronic myeloid leukemia (CML) that is characterized by rapid expansion of therapy-refractory and differentiation-arrested blasts, remains a...
10.
Cano V, Lorentz C, Magdalou J, Loppinet V, Siest G, Ziegler J
Life Sci
. 1997 Jan;
61(1):PL1-8.
PMID: 9200672
A series of inhibitors of the human liver recombinant UDP-glucuronosyltransferase 1*6 derived from uridine were synthetized as probes of the binding site of the cosubstrate, UDP-glucuronic acid. If triphenylmethanol or...